2010
DOI: 10.1016/j.ijrobp.2009.09.074
|View full text |Cite
|
Sign up to set email alerts
|

Primary Tumor Site as a Predictor of Treatment Outcome for Definitive Radiotherapy of Advanced-Stage Oral Cavity Cancers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
25
2

Year Published

2016
2016
2021
2021

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 42 publications
(30 citation statements)
references
References 32 publications
(40 reference statements)
3
25
2
Order By: Relevance
“…In 2011, Boldrup et al emphasized the importance of differentiating the anatomical subsites as well as the histological mucosa conditions to sufficiently evaluate the histomorphological patterns of head and neck cancer [8]. Furthermore, the outcome of radiation therapy in advanced disease has been suggested to be associated with the anatomic location of the tumour [6]. …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In 2011, Boldrup et al emphasized the importance of differentiating the anatomical subsites as well as the histological mucosa conditions to sufficiently evaluate the histomorphological patterns of head and neck cancer [8]. Furthermore, the outcome of radiation therapy in advanced disease has been suggested to be associated with the anatomic location of the tumour [6]. …”
Section: Discussionmentioning
confidence: 99%
“…Several studies have reported specific metastatic pathways according to tumour localization and different responses to radiation therapy depending on the anatomical site [46]. Belbin et al showed that specific biological mechanisms underlying tumour aggressiveness are heavily influenced by the site of the primary tumour [7].…”
Section: Introductionmentioning
confidence: 99%
“…Different subsites of oral cavity cancers, although grouped together, have different natural history and treatment outcomes. The reported incidence of lymph node metastasis in bucco‐alveolar complex lesions is approximately 25%‐30%, whereas in tongue and floor of mouth cancers it ranges up to 75% . In addition, the predictive factors for nodal metastasis are different for the 2 subsites.…”
Section: Discussionmentioning
confidence: 99%
“…The radiation field included the entire tumor bed area (with 1‐ to 2‐cm margins) as well as the regional lymphatics. Concomitant chemoradiotherapy (CRT; 66 Gy) with cisplatin‐based regimens was administered to patients with extracapsular spread (ECS), multiple lymph node metastases, positive margins, or ≥3 minor risk factors (ie, the above‐mentioned minor risk factors plus pT4) . The chemotherapy regimen consisted of intravenous cisplatin 50 mg/m 2 biweekly plus daily oral tegafur 800 mg and leucovorin 60 mg, cisplatin 40 mg/m 2 weekly, or cisplatin 100 mg/m 2 every 3 weeks …”
Section: Methodsmentioning
confidence: 99%